Gene · 2012
NIH grants841
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 841
Download this page as JSON| Grant | Title | EMP1 papers | Newest fiscal year |
|---|---|---|---|
| UG1CA233196 | Johns Hopkins University NCTN Lead Academic Site Program | 1 | 2025 |
| UG1CA233270 | Vanderbilt Network Lead Academic Participating Site for the NCTN | 1 | 2025 |
| UG1CA233290 | Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center | 1 | 2025 |
| UG1CA233320 | Northwestern University Lead Academic Participating Site | 1 | 2025 |
| UG1CA233337 | Yale Cancer Center NCTN LAPS | 1 | 2025 |
| UG1CA233338 | ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies | 1 | 2025 |
| UG1CA233373 | UNC Lead Academic Participating Site | 1 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 1 | 2025 |
| UL1TR002345 | Washington University Institute of Clinical and Translational Sciences | 1 | 2025 |
| UL1TR002384 | Clinical and Translational Science Center | 1 | 2025 |
| ZIAAI000644 | Gene Therapy and Hematopoietic Stem Cell Research to Treat Inherited Primary Immune Deficiencies | 1 | 2025 |
| ZIAAI000645 | Development and Clinical Application of Gene and Cell therapies for Patients with Immune Deficiencies | 1 | 2025 |
| ZIAAI000810 | Vector-Borne Diseases: Biology Of Vector Host Relationship | 1 | 2025 |
| ZIAAI000833 | Antigen Processing And Presentation In The Intestine | 1 | 2025 |
| ZIAAI000989 | Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficiencies | 1 | 2025 |
| ZIAAI001040 | International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs | 1 | 2025 |
| ZIAAI001147 | T Cell Regulatory and Suppression Mechanisms in Malaria | 1 | 2025 |
| ZIAAI001150 | Nitric Oxide and Endothelial Function in Patients with Malaria | 1 | 2025 |
| ZIAAI001153 | Malaria Pathogenesis in Pregnant Women and Young Children | 1 | 2025 |
| ZIAAI001222 | Characterization of the cellular and molecular bases of inborn errors of immunity | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2012/grants?page=9